PE20010858A1 - Derivados de tiazolidindiona como agentes antidiabeticos - Google Patents
Derivados de tiazolidindiona como agentes antidiabeticosInfo
- Publication number
- PE20010858A1 PE20010858A1 PE2000001189A PE0011892000A PE20010858A1 PE 20010858 A1 PE20010858 A1 PE 20010858A1 PE 2000001189 A PE2000001189 A PE 2000001189A PE 0011892000 A PE0011892000 A PE 0011892000A PE 20010858 A1 PE20010858 A1 PE 20010858A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- etoxy
- nr5r6
- halogen
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS AMINO-ETOXI-BENCILTIAZOLIDINDIONA DE FORMULA I, DONDE R1 ES H, ALQUILO C1-C6; R2 ES H, ALQUILO C1-C6, HALOGENO, OR5, SR5, NR5R6, NO2, FENILO; R3 ES H, ALQUILO C1-C6, HALOGENO, OR5, SR5, NR5R6, NO2, FENILO; R4 ES H, ALQUILO C1-C6, HALOGENO, OR5, NR5R6, FENILO; R3 Y R4 JUNTOS FORMAN -HC=CH-CH=CH-, -N=CR7-NR8-, -NR8C(R7)=N-; R5 Y R6 SON H, ALQUILO C1-C6; R7 ES H, NH2; R8 ES H, ALQUILO C1-C6, UN GRUPO a, b. SON COMPUESTOS PREFERIDOS 5-{4-[2-(METIL-PIRIMIDIN-4-IL-AMINO)-ETOXI]-BENCIL}-TIAZOLIDIN-2,4-DIONA; 5-(4-{2-[(6-CLORO-PIRIMIDIN-4-IL)-METIL-AMINO]ETOXI}BENCIL)-TIAZOLIDIN-2,4-DIONA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION; Y AL USO DEL COMPUESTO EN COMBINACION CON SULFONILUREAS, BIGUANIDAS. EL COMPUESTO I PUEDE SER UTIL PARA EL TRATAMIENTO DE HIPERGLICEMIA, HIPERLIPIDEMIA, COMPLICACIONES ASOCIADAS A LA RESISTENCIA A LA INSULINA COMO HIPERTENSION, HIPERURICEMIA, TRASTORNOS CARDIOVASCULARES, METABOLICOS, ENDOCRINOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES009902533A ES2156574B1 (es) | 1999-11-18 | 1999-11-18 | Nuevos derivados de tiazolidindiona como agentes antidiabeticos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010858A1 true PE20010858A1 (es) | 2001-08-22 |
Family
ID=8310628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001189A PE20010858A1 (es) | 1999-11-18 | 2000-11-07 | Derivados de tiazolidindiona como agentes antidiabeticos |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US7001910B1 (es) |
| EP (1) | EP1231211B1 (es) |
| JP (1) | JP2003514817A (es) |
| KR (1) | KR100518110B1 (es) |
| CN (1) | CN1159314C (es) |
| AP (1) | AP1330A (es) |
| AR (1) | AR031080A1 (es) |
| AT (1) | ATE241622T1 (es) |
| AU (1) | AU770045B2 (es) |
| BG (1) | BG106699A (es) |
| BR (1) | BR0015613A (es) |
| CA (1) | CA2391913A1 (es) |
| CO (1) | CO5261560A1 (es) |
| CR (1) | CR6640A (es) |
| CZ (1) | CZ20021654A3 (es) |
| DE (1) | DE60003072T2 (es) |
| DK (1) | DK1231211T3 (es) |
| EA (1) | EA004301B1 (es) |
| EE (1) | EE200200254A (es) |
| ES (2) | ES2156574B1 (es) |
| GE (1) | GEP20043240B (es) |
| HR (1) | HRP20020426A2 (es) |
| HU (1) | HUP0203478A2 (es) |
| IL (1) | IL149634A0 (es) |
| IS (1) | IS2014B (es) |
| MA (1) | MA26844A1 (es) |
| MX (1) | MXPA02005011A (es) |
| NO (2) | NO20022336L (es) |
| NZ (1) | NZ519264A (es) |
| OA (1) | OA12089A (es) |
| PE (1) | PE20010858A1 (es) |
| PL (1) | PL354877A1 (es) |
| PT (1) | PT1231211E (es) |
| SK (1) | SK6752002A3 (es) |
| WO (1) | WO2001036416A1 (es) |
| YU (1) | YU40202A (es) |
| ZA (1) | ZA200203906B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2174748B1 (es) * | 2001-01-31 | 2003-09-16 | Vita Lab | Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos. |
| KR100450700B1 (ko) * | 2002-03-22 | 2004-10-01 | 주식회사종근당 | 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물 |
| US7713983B2 (en) | 2003-03-03 | 2010-05-11 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| CL2004000409A1 (es) | 2003-03-03 | 2005-01-07 | Vertex Pharma | Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu |
| US20050014732A1 (en) * | 2003-03-14 | 2005-01-20 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and an anti-diabetic agent |
| US8283354B2 (en) | 2004-09-02 | 2012-10-09 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| US7928107B2 (en) | 2004-09-02 | 2011-04-19 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| CZ297347B6 (cs) * | 2004-09-21 | 2006-11-15 | Zentiva, A. S. | Zpusob prípravy rosiglitazonu |
| JP5546372B2 (ja) * | 2010-06-30 | 2014-07-09 | 積水メディカル株式会社 | ベンジルヒダントイン化合物の製造法 |
| WO2016184895A1 (en) | 2015-05-18 | 2016-11-24 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Means for detecting or measuring a biological activity of a botulinum toxin |
| US10689374B1 (en) | 2019-07-12 | 2020-06-23 | United Arab Emirates University | Pyrimidine-thiazolidinone derivatives |
| US10702525B1 (en) | 2019-09-04 | 2020-07-07 | United Arab Emirates University | Pyrimidine derivatives as anti-diabetic agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| GB9023583D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
-
1999
- 1999-11-18 ES ES009902533A patent/ES2156574B1/es not_active Expired - Fee Related
-
2000
- 2000-11-06 AR ARP000105830A patent/AR031080A1/es unknown
- 2000-11-07 PE PE2000001189A patent/PE20010858A1/es not_active Application Discontinuation
- 2000-11-14 CO CO00086452A patent/CO5261560A1/es not_active Application Discontinuation
- 2000-11-15 IL IL14963400A patent/IL149634A0/xx unknown
- 2000-11-15 KR KR10-2002-7006298A patent/KR100518110B1/ko not_active IP Right Cessation
- 2000-11-15 DK DK00974559T patent/DK1231211T3/da active
- 2000-11-15 EE EEP200200254A patent/EE200200254A/xx unknown
- 2000-11-15 OA OA1200200148A patent/OA12089A/en unknown
- 2000-11-15 AU AU12815/01A patent/AU770045B2/en not_active Ceased
- 2000-11-15 SK SK675-2002A patent/SK6752002A3/sk unknown
- 2000-11-15 ES ES00974559T patent/ES2199878T3/es not_active Expired - Lifetime
- 2000-11-15 EA EA200200470A patent/EA004301B1/ru not_active IP Right Cessation
- 2000-11-15 CA CA002391913A patent/CA2391913A1/en not_active Abandoned
- 2000-11-15 GE GEAP20006452A patent/GEP20043240B/en unknown
- 2000-11-15 PL PL00354877A patent/PL354877A1/xx not_active IP Right Cessation
- 2000-11-15 MX MXPA02005011A patent/MXPA02005011A/es active IP Right Grant
- 2000-11-15 EP EP00974559A patent/EP1231211B1/en not_active Expired - Lifetime
- 2000-11-15 AP APAP/P/2002/002512A patent/AP1330A/en active
- 2000-11-15 CN CNB008166412A patent/CN1159314C/zh not_active Expired - Fee Related
- 2000-11-15 YU YU40202A patent/YU40202A/sh unknown
- 2000-11-15 AT AT00974559T patent/ATE241622T1/de not_active IP Right Cessation
- 2000-11-15 US US10/130,576 patent/US7001910B1/en not_active Expired - Fee Related
- 2000-11-15 CZ CZ20021654A patent/CZ20021654A3/cs unknown
- 2000-11-15 PT PT00974559T patent/PT1231211E/pt unknown
- 2000-11-15 DE DE60003072T patent/DE60003072T2/de not_active Expired - Fee Related
- 2000-11-15 JP JP2001538905A patent/JP2003514817A/ja active Pending
- 2000-11-15 WO PCT/ES2000/000432 patent/WO2001036416A1/es not_active Application Discontinuation
- 2000-11-15 NZ NZ519264A patent/NZ519264A/en unknown
- 2000-11-15 HU HU0203478A patent/HUP0203478A2/hu unknown
- 2000-11-15 BR BR0015613-2A patent/BR0015613A/pt not_active IP Right Cessation
-
2002
- 2002-05-14 BG BG106699A patent/BG106699A/bg unknown
- 2002-05-15 IS IS6386A patent/IS2014B/is unknown
- 2002-05-15 NO NO20022336A patent/NO20022336L/no not_active Application Discontinuation
- 2002-05-15 CR CR6640A patent/CR6640A/es not_active Application Discontinuation
- 2002-05-15 HR HR20020426A patent/HRP20020426A2/hr not_active Application Discontinuation
- 2002-05-15 MA MA26638A patent/MA26844A1/fr unknown
- 2002-05-16 NO NO20022379A patent/NO20022379D0/no unknown
- 2002-05-16 ZA ZA200203906A patent/ZA200203906B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000947A1 (es) | ACTIVADORES DE hPPARþ Y hPPARO | |
| PE20090884A1 (es) | Compuestos de indol como activadores de glucoquinasa | |
| PE20010858A1 (es) | Derivados de tiazolidindiona como agentes antidiabeticos | |
| PE20081199A1 (es) | Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta-9 desaturasa | |
| PE20090434A1 (es) | Derivados de sulfonil amida como inhibidores de quinasas | |
| PE20091243A1 (es) | Compuesto heterociclico fusionado | |
| RU2398769C2 (ru) | Азотосодержащие гетеробициклические соединения | |
| PE20010406A1 (es) | ACIDO 2-{2-METIL-4[({4-METIL-2[4-(TRIFLUOROMETIL)FENIL]-1,3-TIAZOL-5-IL}METIL)SULFANIL]FENOXI}ACETICO COMO AGONISTA DEL hPPARd | |
| PE20070187A1 (es) | Moduladores de lxr basados en pirazol | |
| PE20141375A1 (es) | Activadores de glucoquinasa | |
| PE20090641A1 (es) | Amidas heterociclicas | |
| HUP0203532A2 (hu) | HPPAR-alfa aktivátor szubsztituált oxazol- és tiazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| PE20061150A1 (es) | Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1) | |
| PE20070189A1 (es) | COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA | |
| PE20120305A1 (es) | Compuestos heterociclicos derivados de benzotiazol y tetrahidroquinolina como inhbidores de bcl-2 y bcl-xl | |
| PE20110299A1 (es) | Nuevos derivados de acilaminobenzamida | |
| AR057970A2 (es) | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus y procedimientos para preprar dichas composiciones | |
| PE20061130A1 (es) | Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a | |
| PE20020585A1 (es) | Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona | |
| PE20091527A1 (es) | Derivados de piridazinona | |
| PE20090949A1 (es) | Compuesto heterociclico y composicion farmaceutica del mismo | |
| PE20000345A1 (es) | Inhibidores enzimaticos | |
| PE20011008A1 (es) | Derivados de pirimidina como inhibidores de ciclooxigenasa 2 | |
| PE20070111A1 (es) | Aminopirimidinas como moduladores de quinasas | |
| PE20040938A1 (es) | Compuestos (2-carboxamido)(3-amino)tiofenos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |